Skip to content
lifestyle.realie.org
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Cue Biopharma, Inc.
Cue Biopharma Announces Appointment of James M. Ahlers as Chief Financial Officer and CUE-221 Investigational New Drug Submission
August 3, 2026
Cue Biopharma Appoints Dominic Borie, M.D., Ph.D., as Chief Medical Officer and Head of Research & Development
July 13, 2026
Cue Biopharma Announces $50.0 Million Private Placement
July 9, 2026
Cue Biopharma Announces Board Transition and Addition of New Directors with Continued Company Evolution
June 2, 2026
Cue Biopharma to Present at the 2026 Jefferies Global Healthcare Conference
May 24, 2026
Cue Biopharma Reports First Quarter 2026 Financial Results and Recent Strategic Developments
May 23, 2026
Cue Biopharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 22, 2026
Cue Biopharma Expands Pipeline with Exclusive License from Ascendant Health Sciences Ltd. for Clinical-Stage Dual-Mechanism Anti-IgE Antibody
May 20, 2026
Cue Biopharma Announces $30 Million Private Placement
May 20, 2026
Cue Biopharma Names Shao-Lee Lin M.D., Ph.D., CEO, President and Board Director to Lead Continued Growth and Transformation into a Clinical-Stage Company
May 20, 2026
1
2
Next Page
→